@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://purl.org/vocab/frbr/core#> .
@prefix ns2: <http://purl.org/spar/pro/> .
@prefix ns3: <http://purl.org/spar/datacite/> .
@prefix ns4: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<> dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/legalcode> .

<https://w3id.org/oc/meta/br/061804320309> a <http://purl.org/spar/fabio/Expression>,
        <http://purl.org/spar/fabio/JournalArticle> ;
    rdfs:label "br 061804320309" ;
    ns4:publicationDate "2024-05-29"^^xsd:date ;
    dcterms:title "The Supplementation Therapy In Autism And Response To Treatment (START) Study: An Open-Label Feasibility Trial Of Ultramicronized Palmitoylethanolamide Potential To Alleviate Psychic Distress Among Autistic Adults" ;
    ns3:hasIdentifier <https://w3id.org/oc/meta/id/06026966167>,
        <https://w3id.org/oc/meta/id/061806206363> ;
    ns2:isDocumentContextFor <https://w3id.org/oc/meta/ar/0618016811779>,
        <https://w3id.org/oc/meta/ar/0618016811780>,
        <https://w3id.org/oc/meta/ar/0618016811781>,
        <https://w3id.org/oc/meta/ar/0618016811782>,
        <https://w3id.org/oc/meta/ar/0618016811783>,
        <https://w3id.org/oc/meta/ar/0618016811784>,
        <https://w3id.org/oc/meta/ar/0618016811785>,
        <https://w3id.org/oc/meta/ar/0618016811786>,
        <https://w3id.org/oc/meta/ar/0618016811787>,
        <https://w3id.org/oc/meta/ar/0618016811788>,
        <https://w3id.org/oc/meta/ar/0618016811789>,
        <https://w3id.org/oc/meta/ar/0618016811790>,
        <https://w3id.org/oc/meta/ar/0618016811791> ;
    ns1:embodiment <https://w3id.org/oc/meta/re/061802752996> ;
    ns1:partOf <https://w3id.org/oc/meta/br/062302018079> .